Business
Surgery Partners, Inc. Announces Third Quarter 2025 Results
BRENTWOOD, Tenn., Nov. 10, 2025 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) (“Surgery Partners” or the “Company”), a leading short-stay surgical
About this update from Surgery Partners, Inc.
[{"type":"text","content":"BRENTWOOD, Tenn., Nov. 10, 2025 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) (“Surgery Partners” or the “Company”), a leading short-stay surgical facility owner and operator, today announced results for the third quarter ended September 30, 2025. Third Quarter 2025 Financial Highlights (All comparisons are year-over-year unless otherwise noted) Revenue increased 6.6% for the third quarter Same-facility revenues increased 6.3% for the third quarter Surgical cases increased 2.1% for the third quarter Same-facility cases increased 3.4% for the third quarter Net loss attributable to Surgery Partners, Inc. was $22.7 million for the third quarter Adjusted EBITDA increased 6.1% to $136.4 million for the third quarter 2025 Guidance Full year 2025 revenue and Adjusted EBITDA guidance to be in the range of $3.275 billion to $3.30 billion and $535 million to $540 million, respectively Eric Evans, Chief Executive Officer, stated, “We are proud to report another quarter of solid execution, with revenue and Adjusted EBITDA growth reflecting continued progress in line with our long-term growth algorithm. The continued strength in orthopedic procedures underpinning our topline growth reinforces our leading positioning within the industry, and we remain committed to operational excellence and disciplined capital deployment to maximize performance of our portfolio. We also continue to evaluate our M&A pipeline and portfolio optimization opportunities and remain encouraged by the multiple levers available to unlock value and drive sustained success.” Dave Doherty, Chief Financial Officer, commented, “Our third quarter performance demonstrates the resilience of our business model and the discipline of our team. Considering that volume and payor mix trends were softer than anticipated, coupled with this year's delayed cadence of capital deployment activities, we have revised our full-year guidance to reflect a prudent approach to the fourth quarter. We remain confident in the strength of our platform, our long-term growth algorithm, and our ability to deliver long-term shareholder value.” Third Quarter 2025 Results Revenues for the third quarter of 2025 increased 6.6% to $821.5 million as compared to $770.4 million for the third quarter of 2024. Same-facility revenues for the third quarter of 2025 increased 6.3% as compared to the same p...